MDXG
MiMedx Group Inc
NASDAQ: MDXG · HEALTHCARE · BIOTECHNOLOGY
$3.97
+0.51% today
Updated 2026-10-29
Market cap
$646.49M
P/E ratio
110.75
P/S ratio
1.82x
EPS (TTM)
$0.04
Dividend yield
—
52W range
$3 – $8
Volume
1.3M
MiMedx Group Inc (MDXG) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$3.97
12-Month target
$5.12
2030 Target
$6.36
Intrinsic (DCF)
$41.37
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.2B | $0.3B | $0.3B | $0.3B | $0.4B | $0.5B | $0.5B | $0.6B | $0.6B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 11.02% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 1.76%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.